Clinical TrialsSearch results
Number of results: 55214
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- A Phase 1, Single-Dose, Multiple-Dose, Food Effect and Drug-Drug Interaction Study of BPN14770
- Health Condition
- Nagata Tsutae
- 2020-11-06
Completed
- A phase 2 open label study to assess the efficacy and safety of beta-glucuronidase enzyme replacement therapy in Japanese patients with mucopolysaccharidosis type VII, Sly disease
- Mucopolysaccharidosis type7
- Osaka City University Hospital Takashi Hamazaki
- 2019-03-11
Completed
- A Phase 2 study of concurrent combination therapy of TFTD (TAS-102) and bevacizumab in patients of more than 70 years of age with unresectable, advanced/recurrent colorectal cancer (KSCC 1602)
- Colorectal Cancer
- Oki Eiji
- 2019-03-20
Completed
- A phase 2 study of osimertinib in elderly patients with non-small-cell lung cancer
- advanced / recurrent non-small cell lung cancer (NSCLC)
- Uchino Junji
- 2018-09-03
Completed
- A Phase 3 Study of KW-0761 (Mogamulizumab) in Subjects with HTLV-1 Associated Myelopathy (HAM)
- HTLV-1 associated Myelopathy (HAM)
- Kyowa Kirin Co., Ltd
- 2018-01-23
Completed
- A Phase 3, Randomized, Multicenter, Open-label, Active-comparator Controlled Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Machaidze Zurab
- 2022-03-04
Completed
- A Phase I Single Ascending Dose Study of RO7126209 in Healthy Japanese Subjects
- Alzheimer's disease
- Nanki Toshihiro
- 2021-05-17
Completed
- A PHASE I SINGLE CENTER, OPEN-LABEL, COMBINATION STUDY OF RM-1929 AND PHOTOIMMUNOTHERAPY IN PATIENTS WITH RECURRENT SQUAMOUS CELL HEAD AND NECK CANCER
- Squamous Cell Carcinoma of Head and Neck
- Arron Sarah
- 2020-09-30
Completed
- A PHASE I STUDY OF CASIRIVIMAB AND IMDEVIMAB IN JAPANESE ADULT VOLUNTEERS
- coronavirus disease 2019(COVID-19)
- Nanki Toshihiro
- 2021-03-29
Completed
- A phase I study of chemoradiotherapy using CBDCA + nab-PTX for elderly stage III NSCLC
- Clinical stage III non-small-cell lung cancer
- Takahashi Toshiaki
- 2019-03-11